
Rodney P. Swartz
Examiner (ID: 3558, Phone: (571)272-0865 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645, 1802, 1641 |
| Total Applications | 1651 |
| Issued Applications | 1191 |
| Pending Applications | 107 |
| Abandoned Applications | 361 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14467763
[patent_doc_number] => 20190185524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => ENGINEERED BOTULINUM NEUROTOXIN
[patent_app_type] => utility
[patent_app_number] => 16/326905
[patent_app_country] => US
[patent_app_date] => 2017-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23029
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -62
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16326905
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/326905 | Engineered botulinum neurotoxin | Aug 23, 2017 | Issued |
Array
(
[id] => 13235023
[patent_doc_number] => 10130695
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-20
[patent_title] => Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease
[patent_app_type] => utility
[patent_app_number] => 15/680629
[patent_app_country] => US
[patent_app_date] => 2017-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10822
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15680629
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/680629 | Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease | Aug 17, 2017 | Issued |
Array
(
[id] => 12702424
[patent_doc_number] => 20180125974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => METHODS AND COMPOSITIONS FOR ENHANCED IMMUNOLOGICAL THERAPY AND TARGETING OF GRAM-POSITIVE BACTERIA
[patent_app_type] => utility
[patent_app_number] => 15/675240
[patent_app_country] => US
[patent_app_date] => 2017-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20683
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15675240
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/675240 | Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria | Aug 10, 2017 | Issued |
Array
(
[id] => 12093792
[patent_doc_number] => 20170350885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'ASSAYS FOR ANTIMICROBIAL ACTIVITY AND APPLICATIONS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/668794
[patent_app_country] => US
[patent_app_date] => 2017-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 42696
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15668794
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/668794 | Assays for antimicrobial activity and applications thereof | Aug 3, 2017 | Issued |
Array
(
[id] => 17350034
[patent_doc_number] => 11224652
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-18
[patent_title] => Multivalent pneumococcal polysaccharide-protein conjugate composition
[patent_app_type] => utility
[patent_app_number] => 16/322698
[patent_app_country] => US
[patent_app_date] => 2017-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12244
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16322698
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/322698 | Multivalent pneumococcal polysaccharide-protein conjugate composition | Aug 3, 2017 | Issued |
Array
(
[id] => 14467849
[patent_doc_number] => 20190185567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => COMBINATIONS FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 16/322926
[patent_app_country] => US
[patent_app_date] => 2017-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24764
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16322926
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/322926 | COMBINATIONS FOR THE TREATMENT OF CANCER | Jul 27, 2017 | Abandoned |
Array
(
[id] => 13207127
[patent_doc_number] => 10117914
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-06
[patent_title] => Sheep nematode vaccine
[patent_app_type] => utility
[patent_app_number] => 15/661727
[patent_app_country] => US
[patent_app_date] => 2017-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 21
[patent_no_of_words] => 14176
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15661727
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/661727 | Sheep nematode vaccine | Jul 26, 2017 | Issued |
Array
(
[id] => 14975523
[patent_doc_number] => 10441648
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-15
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 15/643084
[patent_app_country] => US
[patent_app_date] => 2017-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 16781
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15643084
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/643084 | None | Jul 5, 2017 | Issued |
Array
(
[id] => 16168225
[patent_doc_number] => 10709765
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-14
[patent_title] => Composition for inhibiting survival or growth of tubercle bacillus by adjusting polarization of macrophage, and method using same
[patent_app_type] => utility
[patent_app_number] => 16/315607
[patent_app_country] => US
[patent_app_date] => 2017-07-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 18
[patent_no_of_words] => 3115
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315607
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315607 | Composition for inhibiting survival or growth of tubercle bacillus by adjusting polarization of macrophage, and method using same | Jul 3, 2017 | Issued |
Array
(
[id] => 14715585
[patent_doc_number] => 20190248856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => Listeria-Based Immunogenic Compositions Comprising Wilms Tumor Protein Antigens And Methods Of Use Thereof
[patent_app_type] => utility
[patent_app_number] => 16/315082
[patent_app_country] => US
[patent_app_date] => 2017-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41742
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315082
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315082 | Listeria-Based Immunogenic Compositions Comprising Wilms Tumor Protein Antigens And Methods Of Use Thereof | Jun 29, 2017 | Abandoned |
Array
(
[id] => 15239691
[patent_doc_number] => 20190374631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => METHODS OF PRIMING A SUS' IMMUNE SYSTEM
[patent_app_type] => utility
[patent_app_number] => 16/312946
[patent_app_country] => US
[patent_app_date] => 2017-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14585
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16312946
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/312946 | METHODS OF PRIMING A SUS' IMMUNE SYSTEM | Jun 22, 2017 | Abandoned |
Array
(
[id] => 15814003
[patent_doc_number] => 10632158
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-28
[patent_title] => Use of a hyperimmune egg product to prevent and treat dysbiosis
[patent_app_type] => utility
[patent_app_number] => 15/631216
[patent_app_country] => US
[patent_app_date] => 2017-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 9068
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15631216
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/631216 | Use of a hyperimmune egg product to prevent and treat dysbiosis | Jun 22, 2017 | Issued |
Array
(
[id] => 16861751
[patent_doc_number] => 11020473
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-01
[patent_title] => Compositions and methods comprising measles virus defective interfering particles for the prevention of infectious diseases
[patent_app_type] => utility
[patent_app_number] => 16/311457
[patent_app_country] => US
[patent_app_date] => 2017-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 22
[patent_no_of_words] => 16482
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311457
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/311457 | Compositions and methods comprising measles virus defective interfering particles for the prevention of infectious diseases | Jun 22, 2017 | Issued |
Array
(
[id] => 13035413
[patent_doc_number] => 10039819
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-07
[patent_title] => Attenuated
[patent_app_type] => utility
[patent_app_number] => 15/624345
[patent_app_country] => US
[patent_app_date] => 2017-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 10271
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15624345
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/624345 | Attenuated | Jun 14, 2017 | Issued |
Array
(
[id] => 11979317
[patent_doc_number] => 20170283471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'MODIFIED MICROBIAL TOXIN RECEPTOR FOR DELIVERING AGENTS INTO CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/621159
[patent_app_country] => US
[patent_app_date] => 2017-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 20593
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15621159
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/621159 | MODIFIED MICROBIAL TOXIN RECEPTOR FOR DELIVERING AGENTS INTO CELLS | Jun 12, 2017 | Abandoned |
Array
(
[id] => 13689591
[patent_doc_number] => 20170355750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-14
[patent_title] => HIGH-THROUGHPUT SCREENING OF FUNCTIONAL ANTIBODY FRAGMENTS, IMMUNOCONJUGATE COMPRISING THE SAME, AND ADAPTOR-DRUG CONJUGATE FOR SCREENING
[patent_app_type] => utility
[patent_app_number] => 15/619835
[patent_app_country] => US
[patent_app_date] => 2017-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17081
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15619835
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/619835 | High-throughput screening of functional antibody fragments, immunoconjugate comprising the same, and adaptor-drug conjugate for screening | Jun 11, 2017 | Issued |
Array
(
[id] => 12091269
[patent_doc_number] => 20170348363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'IMMUNE MODULATION FOR ISCHEMIA DISEASE AND ACCELERATION OF RECOVERY AFTER ISCHEMIC EVENTS BY MICROBIOME STIMULATED T REGULATORY CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/611699
[patent_app_country] => US
[patent_app_date] => 2017-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2765
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15611699
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/611699 | IMMUNE MODULATION FOR ISCHEMIA DISEASE AND ACCELERATION OF RECOVERY AFTER ISCHEMIC EVENTS BY MICROBIOME STIMULATED T REGULATORY CELLS | May 31, 2017 | Abandoned |
Array
(
[id] => 14454237
[patent_doc_number] => 10323070
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-18
[patent_title] => VMP-like sequences of pathogenic
[patent_app_type] => utility
[patent_app_number] => 15/609188
[patent_app_country] => US
[patent_app_date] => 2017-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 28124
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15609188
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/609188 | VMP-like sequences of pathogenic | May 30, 2017 | Issued |
Array
(
[id] => 16443657
[patent_doc_number] => 10835561
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-17
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 15/605484
[patent_app_country] => US
[patent_app_date] => 2017-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 101
[patent_figures_cnt] => 101
[patent_no_of_words] => 81630
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 213
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15605484
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/605484 | None | May 24, 2017 | Issued |
Array
(
[id] => 14532493
[patent_doc_number] => 20190201867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => USE OF A HEMOCOMPATIBLE POROUS POLYMER BEAD SORBENT FOR REMOVAL OF ENDOTOXEMIA-INDUCING MOLECULES
[patent_app_type] => utility
[patent_app_number] => 16/303232
[patent_app_country] => US
[patent_app_date] => 2017-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12486
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16303232
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/303232 | Use of a hemocompatible porous polymer bead sorbent for removal of endotoxemia-inducing molecules | May 17, 2017 | Issued |